Source: http://www.asmscience.org/content/book/10.1128/9781555815981.ch40
Timestamp: 2019-04-21 00:25:03+00:00

Document:
Negri bodies. (A) Negri body in a pyramidal neuron; (B) Negri body in a cerebellar Purkinje cell.
1. Albas, A.,, C. I. Ferrari,, L. H. da Silva,, F. Bernardi, and, F. H. Ito. 1999. Influence of canine brain decomposition on laboratory diagnosis of rabies. Rev. Soc. Bras. Med. Trop. 32: 19– 22.
2. Alford, P. L.,, and W. C. Satterfield. 1995. Paralytic illness resembling inflammatory polyradiculoneuropathy in a chimpanzee. J. Am. Vet. Med. Assoc. 207: 83– 85.
3. Alvarez, L.,, R. Fajardo,, E. Lopez,, R. Pedroza,, T. Hemachudha,, N. Kamolvarin,, G. Cortes, and, G. M. Baer. 1994. Partial recovery from rabies in a nine-year-old boy. Pediatr. Infect. Dis. J. 13: 1154– 1155.
4. Anderson, L. J.,, K. G. Nicholson,, R. V. Tauxe, and, W. G. Winkler. 1984. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann. Intern. Med. 100: 728– 735.
5. Anderson, L. J.,, and W. G. Winkler. 1979. Aqueous quaternary ammonium compounds and rabies treatment. J. Infect. Dis. 139: 494– 495.
6. Arai, Y. T.,, K. Yamada,, Y. Kameoka,, T. Horimoto,, K. Yamamoto,, S. Yabe,, M. Nakayama, and, M. Tashiro. 1997. Nucleoprotein gene analysis of fixed and street rabies virus variants using RT-PCR. Arch. Virol. 142: 1787– 1796.
8. Awasthi, M.,, H. Parmar,, T. Patankar, and, M. Castillo. 2001. Imaging findings in rabies encephalitis. Am. J. Neuroradiol. 22: 677– 680.
9. Badrane, H.,, C. Bahloul,, P. Perrin, and, N. Tordo. 2001. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 75: 3268– 3276.
10. Baer, G. M. (ed.). 1991. The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
11. Baer, G. M. 1994. Rabies—an historical perspective. Infect. Agents Dis. 3: 168– 180.
12. Baer, G. M. 1991. Vampire bat and bovine paralytic rabies, p. 389–403. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
13. Bernard, K. W.,, P. W. Smith,, F. J. Kader, and, M. J. Moran. 1982. Neuroparalytic illness and human diploid cell rabies vaccine. JAMA 248: 3136– 3138.
14. Bhatt, D. R.,, M. A. W. Hattwick,, R. Gerdson,, R. W. Emmons, and, H. N. Johnson. 1974. Human rabies: diagnosis, complications, and prognosis. Am. J. Dis. Child. 127: 862– 869.
15. Blancou, J.,, M. F. A. Aubert, and, M. Artois. 1991. Fox rabies, p. 257–290. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
16. Blanton, J. D.,, C. A. Hanlon, and, C. E. Rupprecht. 2007. Rabies surveillance in the United States during 2006. J. Am. Vet. Med. Assoc. 231: 540– 556.
17. Bleck, T. P.,, and S. R. Alston. 1995. Prion diseases, p. 11.1–11.16. In T. P. Bleck (ed.), Atlas of Infectious Diseases, vol. III. Central Nervous System and Eye Infections. (Series editor, G. L. Mandell.) Livingstone, New York, NY.
18. Bleck, T. P.,, and C. E. Rupprecht. 2000. Rabies, p. 1811–1820. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, New York, NY.
19. Bleck, T. P.,, and C. E. Rupprecht. 2005. Rhabdoviruses, p. 2047–2056. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, New York, NY.
20. Bleck, T. P.,, and J. S. Brauner. 2004. Tetanus, p. 625–648. In W. M. Scheld,, R. J. Whitley, and, C. M. Marra (ed.), Infections of the Central Nervous System, 3rd ed. Lippincott Williams % Wilkins, New York, NY.
21. Blenden, D. C.,, W. Creech, and, M. J. Torres-Anjel. 1986. Use of immunofluorescence examination to detect rabies virus in the skin of humans with clinical encephalitis. J. Infect. Dis. 154: 698– 701.
22. Blumberg, B. M.,, C. Giorgi, and, D. Kolakofsky. 1983. N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell 32: 559– 567.
23. Brochier, B.,, D. Boulanger,, F. Costy, and, P.-P. Pastoret. 1994. Toward rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 12: 1368– 1371.
24. Bryceson, A. D.,, B. M. Greenwood,, D. A. Warrell,, N. M. Davidson,, H. M. Pope,, J. H. Lawrie,, H. J. Barnes,, W. E. Bailie, and, G. E. Wilcox. 1975. Demonstration during life of rabies antigen in humans. J. Infect. Dis. 131: 71– 74.
25. Bundza, A.,, and K. M. Charlton. 1988. Comparison of spongiform lesions in experimental scrapie and rabies in skunks. Acta Neuropathol. 3: 275– 280.
26. Bunn, T. O. 1991. Cat rabies, p. 380–387. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
27. Burton, E. C.,, D. K. Burns,, M. J. Opatowsky,, W. H. El-Feky,, B. Fischbach,, L. Melton,, E. Sanchez,, H. Randall,, D. L. Watkins,, J. Chang, and, G. Klintmalm. 2005. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch. Neurol. 62: 873– 882.
28. Camelo, S.,, M. Lafage, and, M. Lafon. 2000. Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J. Neurovirol. 6: 507– 518.
29. Cantor, S. B.,, R. D. Clover, and, R. F. Thompson. 1994. A decision-analytic approach to postexposure rabies prophylaxis. Am. J. Public. Health 84: 1144– 1148.
30. Ceccaldi, P. E.,, J. P. Gillet, and, H. Tsiang. 1989. Inhibition of the transport of rabies virus in the central nervous system. J. Neuropathol. Exp. Neurol. 48: 620– 630.
31. Centers for Disease Control. 1992. Extension of the raccoon rabies epizootic—United States, 1992. Morb. Mortal. Wkly. Rep. 41: 661– 664.
32. Centers for Disease Control and Prevention. 1994. Raccoon rabies epizootic—United States, 1993. Morb. Mortal. Wkly. Rep. 43: 269– 273.
33. Centers for Disease Control and Prevention. 1995. Human rabies—Alabama, Tennessee, and Texas, 1994. Morb. Mortal. Wkly. Rep. 44: 269– 272.
34. Centers for Disease Control and Prevention. 1996. Human rabies—Connecticut, 1995. Morb. Mortal. Wkly. Rep. 45: 207– 209.
35. Centers for Disease Control and Prevention. 1995. Translocation of coyote rabies—Florida, 1994. Morb. Mortal. Wkly. Rep. 44: 580– 587.
36. Centers for Disease Control and Prevention. 1999. Human rabies prevention—United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 48 (RR-1) : 1– 41.
37. Centers for Disease Control and Prevention. 2003. First human death associated with raccoon rabies—Virginia, 2003. Morb. Mortal. Wkly. Rep. 2003; 52: 1102– 1103.
38. Charlton, K. M. 1994. The pathogenesis of rabies and other lyssaviral infections: recent studies, p. 95–119. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.), Lyssaviruses. Springer-Verlag, Berlin, Germany.
39. Cheetham, H. D.,, J. Hart,, N. F. Coghill, and, B. Fox. 1970. Rabies with myocarditis. Two cases in England. Lancet i: 921– 922.
40. Childs, J. E.,, C. V. Trimarchi, and, J. W. Krebs. 1994. The epidemiology of bat rabies in New York State, 1988–92. Epidemiol. Infect. 113: 501– 511.
41. Chopra, J. S.,, A. K. Banerjee,, J. M. K. Murthy, and, S. R. Pal. 1980. Paralytic rabies: a clinicopathologic study. Brain 103: 789– 802.
42. Chutivongse, S.,, H. Wilde,, M. Benjavongkulchai,, P. Chomchey, and, S. Punthawong. 1995. Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin. Infect. Dis. 20: 818– 820.
43. Clark, K. A.,, S. U. Neill,, J. S. Smith,, P. J. Wilson,, V. W. Whadford, and, G. W. McKirihan. 1994. Epizootic canine rabies transmitted by coyotes in south Texas. J. Am. Vet. Med. Assn. 204: 536– 540.
44. Cohen, S. L.,, S. Gardner,, C. Lanyi,, J. R. McDonald,, H. Ree,, P. A. Southorn and, A. W. Woodruff. 1976. A case of rabies in man: some problems of diagnosis and management. Br. Med. J. 1: 1041– 1042.
45. Coll, J. M. 1995. The glycoprotein G of rhabdoviruses. Arch. Virol. 140: 827– 851.
46. Constantine, D. G. 1967. Rabies Transmission by Air in Bat Caves. U.S. Public Health Service, Washington, DC.
48. Crepin, P.,, L. Audry,, Y. Rotivel,, A. Gacoin,, C. Caroff, and, H. Bourhy. 1998. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol. 36: 1117– 1121.
49. Dean, D. J. 1963. Pathogenesis and prophylaxis of rabies in man. N. Y. State J. Med. 63: 3507– 3513.
50. De Brito, T.,, M. D. Araujo, and, A. Tiriba. 1973. Ultrastructure of the Negri body in human rabies. J. Neurol. Sci. 20: 363– 372.
51. Delmas, O.,, E. C. Holmes,, C. Talbi,, F. Larrous,, L. Dacheux,, C. Bouchier, and, H. Bourhy. 2008. Genomic diversity and evolution of the lyssaviruses. PLoS ONE 3: e2057.
52. de Mattos, C. A.,, C. C. de Mattos, and, C. E. Rupprecht. 2001. Rhabdoviruses, p. 1245–1277. In B. N. Fields,, D. M. Knipe, and, P. M. Howley (ed.), Fields Virology, 4th ed. Lippincott Williams % Wilkins, Philadelphia, PA.
53. De Serres, G,, F. Dallaire,, M. Côte, and, D. M. Skowronski. 2008. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin. Infect. Dis. 46: 1329– 1337.
54. Dietzschold, B. 1993. Antibody-mediated clearance of viruses from the mammalian central nervous system. Trends Microbiol. 1: 63– 66.
55. Dorfman, N.,, B. Dietschold,, W. Kajiyama,, Z. F. Fu,, H. Koprowski, and, A. L. Notkins. 1994. Development of human monoclonal antibodies to rabies. Hybridoma 13: 397– 402.
56. Dubois-Dalcq, M.,, K. V. Holmes, and, B. Rentier. 1984. Assembly of rhabdoviridae, p. 21–43. In M. Dubois-Dalcq,, K. V. Holmes,, B. Rentier,, B. Dietzschold, and, H. Koprowski (ed.), Assembly of Enveloped RNA Viruses. Springer-Verlag, Vienna, Austria.
57. Dupont, J. R.,, and K. M. Earle. 1965. Human rabies encephalitis. A study of forty-nine fatal cases with a review of the literature. Neurology 15: 1023– 1034.
58. Dürr, S.,, S. Naïssengar,, R. Mindekem,, C. Diguimbye,, M. Niezgoda,, I. Kuzmin,, C. E. Rupprecht, and, J. Zinsstag. 2008. Rabies diagnosis for developing countries. PLoS Negl. Trop. Dis. 2: e206.
59. Dutta, J. K.,, and T. K. Dutta. 1994. Treatment of clinical rabies in man: drug therapy and other measures. Clin. Pharmacol. Ther. 32: 594– 597.
61. Eng, T. R.,, D. B. Fishbein,, H. E. Talamante,, M. Fekadu,, G. F. Chavez,, F. J. Muro, and, G. M. Baer. 1994. Immunogenicity of rabies vaccines used during an urban epizootic of rabies in Mexico. Vaccine 12: 1259– 1306.
62. Esiri, M. M.,, and P. G. E. Kennedy. 1992. Virus diseases, p. 335–399. In J. H. Adams, and, L. W. Duchen (ed.), Greenfield’s Neuropathology. Oxford University Press, New York, NY.
63. Fekadu, M.,, F. W. Chandler, and, A. K. Harrison. 1982. Pathogenesis of rabies in dogs inoculated with an Ethiopian rabies virus strain. Immunofluorescence, histologic and ultrastructural studies of the central nervous system. Arch. Virol. 71: 109– 126.
64. Fekadu, M. 1991. Canine rabies, p. 367–378. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
65. Fine, S. M. 2005. Vesicular stomatitis virus and related viruses, p. 2044–2047. In G. L. Mandell,, J. E. Bennett, and, R. Dolin (ed.), Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, New York, NY.
66. Fishbain, D. A.,, S. Barsky, and, M. Goldberg. 1992. Monosymptomatic hypochondriacal psychosis: belief of contracting rabies. Int. J. Psychiatry Med. 22: 3– 9.
68. Fishbein, D. B. 1991. Rabies in humans, p. 519–549. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
69. Fleming, G. 1872. Rabies and hydrophobia, p. 7. Chapman and Hall, London, England.
70. Foley, G. L.,, and J. F. Zachary. 1995. Rabies-induced spongiform change and encephalitis in a heifer. Vet. Pathol. 32: 309– 311.
71. Gastaut, H.,, and G. Miletto. 1955. Interprétation physiopathogénetique de la rage furieuse. Rev. Neurol. 92: 1– 25.
72. Gibbons, R. V.,, and C. E. Rupprecht. 2001. Postexposure rabies prophylaxis in immunocompromised patients. JAMA 285: 1574– 1575.
73. Gode, G. R.,, A. V. Raju,, T. S. Jayalakshmi,, H. L. Kaul, and, N. K. Bhide. 1976. Intensive care in rabies therapy: clinical observations. Lancet ii: 6– 8.
74. Gode, G. R.,, R. Saksena,, R. K. Batra,, P K. Kalia, and, N. K. Bhide. 1988. Treatment of 54 clinically diagnosed rabies patients with two survivals. Indian J. Med. Res. 88: 564– 566.
75. Goldwasser, R. A.,, and R. E. Kissling. 1958. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc. Soc. Exp. Biol. Med. 98: 219– 223.
76. Gosztonyi, G. 1994. Reproduction of lyssaviruses: ultra-structural composition of lyssaviruses and functional aspects of pathogenesis, p. 43–68. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.), Lyssaviruses. Springer-Verlag, Berlin, Germany.
77. Goto, H.,, N. Minimoto,, H. Ito,, T. R. Luo,, M. Sugiyama,, T. Kinjo, and, A. Kawai. 1995. Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites. Arch. Virol. 140: 1061– 1074.
78. Gourmelon, P.,, D. Briet,, D. Clarençon,, L. Court, and, H. Tsiang. 1991. Sleep alterations in experimental street rabies virus infection occur in the absence of major EEG abnormalities. Brain Res. 554: 159– 165.
79. Gourmelon, P.,, D. Briet,, L. Court, and, H. Tsiang. 1986. Electrophysiological and sleep alterations in experimental mouse rabies. Brain Res. 398: 128– 140.
80. Gowers, W. R. 1888. A Manual of Diseases of the Nervous System, p. 1237–1254. P. Blakiston % Co., Philadelphia, PA.
81. Gubala, A. J.,, D. F. Proll,, R. T. Barnard,, C. J. Cowled,, S. G. Crameri,, A. D. Hyatt, and, D. B. Boyle. 2008. Genomic characterisation of Wongabel virus reveals novel genes within the Rhabdoviridae. Virology 376: 13– 23.
82. Hanley, D. F.,, J. D. Glass,, J. C. McArthur, and, R. T. Johnson. 1995. Viral encephalitis and related conditions, p. 3.24–3.28. In T. P. Bleck (ed.), Atlas of Infectious Diseases, vol. III. Central Nervous System and Eye Infections. (Series editor, G. L. Mandell.) Churchill Livingstone, Inc., New York, NY.
83. Hansom, R. P. 1952. The natural history of vesicular stomatitis. Bacteriol. Rev. 16: 179– 204.
84. Haour, F.,, C. Marquette,, E. Ban,, M. Crumeyrolle-Arias,, W. Rostene,, H. Tsiang, and, G. Fillion. 1995. Receptors for interleukin-1 in the central nervous system and neuroendocrine systems. Ann. Endocrinol. 56: 173– 179.
85. Hellenbrand, W.,, C. Meyer,, G. Rasch,, I. Steffens, and, A. Ammon. 2005. Cases of rabies in Germany following organ transplantation. Euro. Surveill. 10: E0502.
86. Hemachuda, T.,, E. Mitrabhakdi,, H. Wilde,, A. Vejabhuti,, S. Siripataravanit, and, D. Kingnate. 1999. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin. Infect. Dis. 28: 143– 144.
87. Hemachuda, T.,, P. Phanuphak, and, B. Sriwanthana. 1988. Immunologic study of human encephalitic and paralytic rabies. A preliminary study of 16 patients. Am. J. Med. 84: 673– 677.
88. Hemachuda, T. 1994. Human rabies: clinical aspects, pathogenesis, and potential therapy, p. 121–143. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.), Lyssaviruses. Springer-Verlag, Berlin, Germany.
89. Hemachuda, T. 1989. Rabies. Handb. Clin. Neurol. 56: 383– 404.
90. Hemachudha, T.,, D. E. Griffin,, R. T. Johnson, and, J. J. Giffels. 1988. Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine. Neurology 38: 42– 44.
91. Hemachudha, T.,, K. Phanthumchinda,, P. Phanuphak, and, S. Manatsathit. 1987. Myoedema as a clinical sign in paralytic rabies. Lancet i: 1210.
92. Hooper, D. C.,, S. T. Ohnishi,, R. Kean,, Y. Numagami,, B. Dietzschold, and, H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92: 5312– 5316.
93. Hooper, P. T.,, G. C. Fraxer,, R. A. Foster, and, G. J. Storie. 1999. Histopathology and immunohistochemistry of bats infected by Australian bat lyssavirus. Aust. Vet. J. 77: 595– 599.
94. Houff, S. A.,, R. C. Burton,, R. W. Wilson,, T. E. Henson,, W. T. London,, G. M. Baer,, L. J. Anderson,, W. G. Winkler,, D. L. Madden, and, J. L. Sever. 1979. Human-to-human transmission of rabies virus by corneal transplant. N. Engl. J. Med. 300: 603– 604.
95. Ito, N.,, M. Sugiyama,, K. Oraveerakul,, P. Piyaviriyakul,, B. Lumlertdacha,, Y. T. Arai,, Y. Tamura,, Y. Mori, and, N. Minamoto. 1999. Molecular epidemiology of rabies in Thailand. Microbiol. Immunol. 43: 551– 559.
96. Jackson, A. C.,, C. C. Phelan, and, J. P. Rossiter. 2000. Infection of Bergmann glia in the cerebellum of a skunk experimentally infected with street rabies virus. Can. J. Vet. Res. 64: 226– 228.
97. Jackson, A. C.,, M. J. Warrell,, C. E. Rupprecht,, W. H. Wunner,, T. P. Bleck, and, H. Wilde. 2003. Management of rabies in humans. Clin. Infect. Dis. 36: 60– 63.
98. Jackson, A. C. 2000. Rabies. Curr. Treatment Options Neurol. 2: 369– 373.
99. Jackson, A. C. 2005. Recovery from rabies. N. Engl. J. Med. 352: 2549– 2550.
100. Jaijaroensup, W.,, S. Limusanno,, P. Khawplod,, K. Serikul,, P. Chomchay,, W. Kaewchompoo,, T. Tantawichien, and, H. Wilde. 1999. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J. Travel Med. 6: 234– 237.
101. Jaijaroensup, W.,, T. Tantawichien,, P. Khawplod,, S. Tepsumethanon, and, H. Wilde. 1999. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 28: 913– 914.
102. Johnson, R. T. 1994. Slow infections of the central nervous system caused by conventional viruses. Ann. N. Y. Acad. Sci. 724: 6– 13.
103. Kasempimolporn, S.,, T. Hemachuda,, P. Khawplod, and, S. Manatsathit. 1991. Human immune response to rabies nucleocapsid and glycoprotein antigens. Clin. Exp. Immunol. 84: 195– 199.
104. Kawai, A.,, and K. Morimoto. 1994. Functional aspects of lyssavirus proteins, p. 27–42. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.), Lyssaviruses. Springer-Verlag, Berlin, Germany.
105. Komsuoglu, S. S.,, F. Dora, and, O. Kalabay. 1981. Periodic EEG activity in human rabies encephalitis. J. Neurol. Neurosurg. Psychiatry 44: 264– 265.
106. Koschel, K.,, and P. Munzel. 1984. Inhibition of opiate receptor-mediated signal transmission by rabies virus in persistently infected NG-108-15 mouse neuroblastoma–rat glioma hybrid cells. Proc. Natl. Acad. Sci. USA 81: 950– 954.
107. Krebs, J. W.,, C. E. Rupprecht, and, J. E. Childs. 2000. Rabies surveillance in the United States during 1999. J. Am. Vet. Med. Assoc. 217: 1799– 1811.
108. Kreindel, S. M.,, M. McGuill,, M. Meltzer,, C. Rupprecht, and, A. DeMaria Jr. 1998. The cost of rabies postexposure prophylaxis: one state’s experience. Public Health Rep 113: 247– 251.
109. Kuzmin, I. V.,, X. Wu,, N. Tordo, and, C. E. Rupprecht. 2008. Complete genomes of Aravan, Khujand, Irkut, and West Caucasian bat viruses, with special attention to the polymerase gene and noncoding regions. Virus Res. 136: 81– 90.
110. Lang, J.,, G. H. Simanjuntak,, S. Soerjosembodo, and, C. Koesharyono. 1998. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of postexposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Bull. W. H. O. 76: 491– 495.
111. Lentz, T. L.,, T. G. Burrage,, A. L. Smith,, J. Crick, and, G. H. Tignor. 1982. Is the acetylcholine receptor a rabies virus receptor? Science 215: 182– 184.
112. Lentz, T. L.,, P. T. Wilson,, E. Hawrot, and, D. W. Speicher. 1984. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 226: 847– 848.
113. Levy, J. A.,, H. Fraenkel-Conrat, and, R. A. Owens. 1994. Virology, p. 77–85. Prentice Hall, Englewood Cliffs, NJ.
114. Lockhart, B. P.,, N. Tordo, and, H. Tsiang. 1992. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob. Agents Chemother. 36: 1750– 1755.
115. Lopez, A.,, P. Miranda,, E. Tejada, and, D. B. Fishbein. 1992. Outbreak of human rabies in the Peruvian jungle. Lancet 339: 408– 411.
116. MacInnes, C. D.,, S. M. Smith,, R. R. Tinline,, N. R. Ayers,, P. Bachmann,, D. G. Ball,, L. A. Calder,, S. J. Crosgrey,, C. Fielding,, P. Hauschildt,, J. M. Honig,, D. H. Johnston,, K. F. Lawson,, C. P. Nunan,, M. A. Pedde,, B. Pond,, R. B. Stewart, and, D. R. Voigt. 2001. Elimination of rabies from red foxes in eastern Ontario. J. Wildl. Dis. 37: 119– 132.
117. Mann, J. M.,, M. J. Burkhart, and, O. J. Rollag. 1980. Anti-rabies treatment in New Mexico: impact of a comprehensive consultations-biologics system. Am. J. Public Health 70: 128– 132.
118. Matter, H. C.,, H. Kharmachi,, N. Haddad,, S. Ben Youseff,, C. Sghaier,, R. Ben Khelifa,, J. Jemli,, L. Mirabet,, F. X. Meslin, and, A. I. Wandeler. 1995. Test of three bait types for oral immunization of dogs against rabies in Tunisia. Am. J. Trop. Med. Hyg. 52: 489– 495.
119. McDermid, R. C.,, L. Saxinger,, B. Lee,, J. Johnstone,, R. T. Gibney,, M. Johnson, and, S. M. Bagshaw. 2008. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can. Med. Assoc. J. 178: 557– 561.
120. Mebatsion, T.,, F. Weiland, and, K. K. Conzelmann. 1999. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73: 242– 250.
121. Meslin, F.-X.,, D. B. Fishbein, and, H. C. Matter. 1994. Rationale and prospects for rabies elimination in developing countries, p. 1–26. In C. E. Rupprecht,, B. Dietzschold, and, H. Koprowski (ed.), Lyssaviruses. Springer-Verlag, Berlin, Germany.
122. Metze, K.,, and W. Feiden. 1991. Rabies virus ribonucleoprotein in the heart. N. Engl. J. Med. 324: 1814– 1815.
123. Morimoto, K.,, D. C. Hooper,, S. Spitsin,, H. Koprowski, and, B. Dietzschold. 1999. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73: 510– 518.
124. Morimoto, K.,, J. P. McGettigan,, H. D. Foley,, D. C. Hooper,, B. Dietzschold, and, M. J. Schnell. 2001. Genetic engineering of live rabies vaccine. Vaccine 19: 3543– 3551.
125. Morimoto, K.,, Y.-J. Ni, and, A. Kawai. 1992. Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic G proteins of the rabies virus. Virology 189: 203– 216.
126. Murphy, F. A.,, S. P. Bauer,, A. K. Harrison, and, W. C. Winn. 1973. Comparative pathogenesis of rabies and rabies-like viruses. Infection of the central nervous system and centrifugal spread to peripheral tissues. Lab. Investig. 29: 1– 16.
127. Murthy, J. M. 1998. MRI in acute disseminated encephalomyelitis following Semple antirabies vaccine. Neuroradiology 40: 420– 423.
128. Nadin-Davis, S. A. 1998. Polymerase chain reaction protocols for rabies virus discrimination. J. Virol. Methods 75: 1– 8.
129. National Association of State Public Health Veterinarians, Inc. (NASPHV) and Centers for Disease Control and Prevention (CDC). 2008. Compendium of animal rabies prevention and control, 2008: National Association of State Public Health Veterinarians, Inc. (NASPHV). Morb. Mortal. Wkly. Rep. Recomm. Rep. 57 (RR-2) : 1– 9.
130. Negri, A. 1903. Zur Aetiologie der Tollwuth. Die Diagnose der Tollwuth auf Grund der neuen Befunde. Z. Hyg. Infectionskr. 44: 519– 540.
131. Negri, A. 1909. Uber die Morphologie und den Entwicklungszyklus des Parasiten der Tollwut (Neurorcytes Hydrophobiae Calkins). Z. Hyg. Infektionskr. 43: 507– 526.
132. Oon, C. T. 2000. Boerhaave’s syndrome (ruptured oesophagus) in a case of rabies. Singap. Med. J. 41: 83– 85.
133. Otvos, L.,, G. R. Krivulka,, L. Urge,, G. I. Szendrei,, L. Nagy,, Z. Q. Xiang, and, H. C. J. Ertl. 1995. Comparison of the effects of amino acid substitutions and beta- N- vs. alpha- O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein. Biochim. Biophys. Acta 1267: 55– 64.
134. Pearlman, E.,, and S. Ballas. 1994. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch. Pathol. Lab. Med. 118: 805– 806.
135. Perrin, P.,, Y. Jacob, and, N. Tordo. 2000. DNA-based immunization against Lyssaviruses. Intervirology 43: 302– 311.
136. Petricciani, J. C. 1993. Ongoing tragedy of rabies. Lancet 342: 1067– 1068.
137. Pleasure, S. J.,, and N. J. Fischbein. 2000. Correlation of clinical and neuroimaging findings in a case of rabies encephalitis. Arch. Neurol. 57: 1765– 1769.
138. Plotkin, S. A.,, and H. Koprowski. 1994. Rabies vaccine, p. 649–670. In S. A. Plotkin, and, E. A. Mortimer (ed.), Vaccines, 2nd ed. W. B. Saunders, Philadelphia, PA.
140. Prosniak, M.,, D. C. Hooper,, B. Dietzschold, and, H. Koprowski. 2001. Effect of rabies virus infection on gene expression in mouse brain. Proc. Natl. Acad. Sci. USA 98: 2758– 2763.
141. Pulmanausahakul, R.,, J. Li,, M. J. Schnell, and, B. Dietzschold. 2008. The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J. Virol. 82: 2330– 2338.
142. Ray, N. B.,, L. C. Ewalt, and, D. L. Lodmell. 1995. Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J. Virol. 69: 764– 772.
143. Reif, J. S.,, P. A. Webb,, T. P. Monath,, J. K. Emerson,, J. D. Poland,, G. E. Kemp, and, G. Cholas. 1987. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups. Am. J. Trop. Med. Hyg. 36: 177– 182.
144. Rose, J. K.,, and M. A. Whitt. 2001. Rhabdoviruses: the viruses and their replication, p. 1221–1244. In B. N. Fields,, D. M. Knipe, and, P. M. Howley (ed.), Fields Virology, 4th ed. Lippincott Williams % Wilkins, Philadelphia, PA.
145. Rupprecht, C. E.,, B. Dietzschold,, W. H. Wunner, and, H. Koprowski. 1991. Antigenic relationships of lyssaviruses, p. 69–100. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
146. Rupprecht, C. E.,, C. A. Hanlon,, M. Niezgoda,, J. R. Buchanan,, D. Diehl, and, H. Koprowski. 1993. Recombinant rabies vaccines: efficacy assessment in free-ranging animals. Onderstepoort J. Vet. Res. 60: 463– 468.
147. Rupprecht, C. E.,, J. S. Smith,, M. Fekadu, and, J. E. Childs. 1995. The ascension of wildlife rabies: a cause for public health concern or intervention? Emerg. Infect. Dis. 1: 107– 114.
148. Rupprecht, C. E.,, and J. S. Smith. 1994. Raccoon rabies: the re-emergence of an epizootic in a densely populated area. Semin. Virol. 5: 155– 164.
149. Samaratunga, H.,, J. W. Searle, and, N. Hudson. 1998. Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathol. Appl. Neurobiol. 24: 331– 335.
150. Schmida, T. O. 1995. Resurgence of rabies. Arch. Pediatr. Adolesc. Med. 149: 1043.
151. Schneider, L. G. 1995. Rabies virus vaccines. Dev. Biol. Stand. 84: 49– 54.
152. Seif, I.,, P. Coulon,, P. E. Rollin, and, A. Flamand. 1985. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53: 926– 934.
153. Shah, H.,, T. Patankar,, S. Prasad, and, B. Vakil. 1999. Post-vaccinal diffuse myelitis: magnetic resonance imaging features. J. Assoc. Physicians India 47: 929– 930.
155. Smith, J. S.,, P. A. Yager, and, G. M. Baer. 1973. A rapid reproducible test for determining rabies neutralizing antibody. Bull. W. H. O. 48: 535– 541.
156. Sokol, F.,, H. D. Schlumberger,, T. K. Wiktor,, H. Koprowski, and, K. Hummeler. 1969. Biochemical and biophysical studies on the nucleocapsid and on the RNA of rabies virus. Virology 38: 651– 665.
157. Speare, R.,, L. Skerratt,, R. Foster,, L. Berger,, P. Hooper,, R. Lunt,, D. Blair,, D. Hansman,, M. Goulet, and, S. Cooper. 1997. Australian bat lyssavirus infection in three fruit bats from north Queensland. Commun. Dis. Intell. 21: 117– 120.
158. Steele, J. H.,, and P. J. Fernandez. 1991. History of rabies and global aspects, p. 1–24. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
159. Stoeckle, M. 1990. Vesicular stomatitis virus and related viruses, p. 1289–1291. In G. L. Mandell,, R. G. Douglas, Jr., and, J. E. Bennett (ed.), Principles and Practice of Infectious Disease, 3rd ed. Churchill Livingstone, New York, NY.
160. Sung, J. H.,, M. Hayano,, A. R. Mastri, and, T. Okagaki. 1976. A case of human rabies and ultrastructure of the Negri body. J. Neuropathol. Exp. Neurol. 35: 541– 559.
161. Sureau, P.,, D. Portnoi,, D. Rollin,, C. Lapresle,, C. Lapresle, and, A. Chaouhi-Berbich. 1981. Prevention de la transmission inter-humaine de la rage greffe de cornee. C. R. Seances Acad. Sci. 293: 689– 692.
162. Tandale, B. V.,, S. S. Tikute,, V. A. Arankalle,, P. S. Sathe,, M. V. Joshi,, S. N. Ranadive,, P. C. Kanojia,, D. Eshwarachary,, M. Kumarswamy, and, A. C. Mishra. 2008. Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India. J. Med. Virol. 80: 118– 124.
163. Tierkel, E. S.,, H. Koprowski,, J. Black, and, R. H. Gorrie. 1949. Preliminary observations in the comparative prophylactic vaccination of dogs against rabies with living virus vaccines and phenolized vaccine. J. Am. Vet. Res. 10: 361– 376.
164. Tordo, N.,, O. Poch,, A. Ermine,, G. Keith, and, F. Rougeon. 1988. Completion of the rabies virus genome sequence determination: highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses. Virology 165: 565– 576.
165. Tordo, N.,, O. Poch,, A. Ermine,, G. Keith, and, F. Rougeon. 1986. Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc. Natl. Acad. Sci. USA 83: 3914– 3918.
166. Torvaldsen, S.,, and T. Watson. 1998. Rabies prophylaxis in Western Australia: the impact of Australian bat lyssavirus. Commun. Dis. Intell. 22: 149– 152.
167. Tsiang, H. 1992. Pathogenesis of rabies virus infection of the nervous system. Adv. Virus Res. 42: 375– 412.
168. Turner, G. S. 1976. A review of the world epidemiology of rabies. Trans. R. Soc. Trop. Med. Hyg. 70: 175– 178.
169. Udawat, H.,, H. R. Chaudhary,, R. K. Goyal,, V. K. Chaudhary, and, R. Mathur. 2001. Guillain-Barre syndrome following antirabies Semple vaccine—a report of six cases. J. Assoc. Physicians India 49: 384– 385.
170. Ugolini, G. 1995. Specificity of rabies virus as a transneuronal tracer of motor networks: transfer from hypoglossal motoneurons to connected second-order and higher order central nervous system cell groups. J. Comp. Neurol. 356: 457– 480.
171. Warrell, D. A.,, N. M. Davidson,, H. M. Pope,, W. E. Bailie,, J. H. Lawrie,, L. D. Ormerod,, A. Kertesz, and, P. Lewis. 1976. Pathophysiologic studies in human rabies. Am. J. Med. 60: 180– 190.
172. Warrell, D. A. 1976. The clinical picture of rabies in man. Trans. R. Soc. Trop. Med. Hyg. 701: 188– 195.
173. Warrell, M. J.,, S. Looareesuwan,, S. Manatsathit,, N. J. White,, P. Phuapradit,, A. Vejjajiva,, C. H. Hoke,, D. S. Burke, and, D. A. Warrell. 1988. Rapid diagnosis of rabies and post-vaccinal encephalitides. Clin. Exp. Immunol. 71: 229– 234.
174. Warrell, M. J. 2008. Emerging aspects of rabies infection: with a special emphasis on children. Curr. Opin. Infect. Dis. 21: 251– 257.
175. Watson, H. D.,, G. H. Tignor, and, A. L. Smith. 1981. Entry of rabies virus into the peripheral nerves of mice. J. Gen. Virol. 56: 371– 382.
176. Weli, S. C.,, C. A. Scott,, C. A. Ward, and, A. C. Jackson. 2006. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J. Virol. 80: 10270– 10273.
177. Whitby, J. E.,, P. Johnstone, and, C. Sillero-Zubiri. 1997. Rabies virus in the decomposed brain of an Ethiopian wolf detected by nested reverse transcription-polymerase chain reaction. J. Wildl. Dis. 33: 912– 915.
178. Whitley, R. J.,, and M. Middlebrooks. 1991. Rabies, p. 127–144. In W. M. Scheld,, R. J. Whitley, and, D. T. Durack (ed.), Infections of the Central Nervous System. Raven Press, New York, NY.
179. Whitley, R. J. 1990. Viral encephalitis. N. Engl. J. Med. 323: 242– 250.
180. Wiktor, T. J.,, P. C. Doherty, and, H. Koprowski. 1977. Suppression of cell mediated immunity by street rabies virus. J. Exp. Med. 145: 1617– 1622.
181. Wilde, H.,, P. Tipkong, and, P. Khawplod. 1999. Economic issues in postexposure rabies treatment. J. Travel Med. 6: 238– 242.
182. Wilde, H.,, S. Sirikawin,, A. Sabcharoen,, D. Kingate,, T. Tantawichien,, P. A. Harischandra,, N. Chaiyabutr,, D. G. de Silva,, L. Fernando,, J. B. Liyanage, and, V. Sitprija. 1996. Failure of postexposure treatment of rabies in children. Clin. Infect. Dis. 22: 228– 232.
183. Willoughby, R. E.,, Jr., K. S. Tieves,, G. M. Hoffman,, N. S. Ghanayem,, C. M. Amlie-Lefond,, M. J. Schwabe,, M. J. Chusid, and, C. E. Rupprecht. 2005. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352: 2508– 2514.
184. World Health Organization. 2005. WHO Expert Consultation on Rabies: First Report. World Health Organization, Geneva, Switzerland.
185. World Health Organization. 1973. Sixth Report of the Expert Committee on Rabies. Technical report series 523. World Health Organization, Geneva, Switzerland.
186. World Health Organization. 2001. World Survey of Rabies N° 34 for the year 1998. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.3.pdf.
187. Wunner, W. H. 1991. The chemical composition and molecular structure of rabies viruses, p. 31–67. In G. M. Baer (ed.), The Natural History of Rabies, 2nd ed. CRC Press, Boca Raton, FL.
188. Xiang, Z. Q.,, S. L. Spitalnik,, J. Cheng,, J. Erikson,, B. Wojczyk, and, H. C. J. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209: 569– 579.
189. Zaidman, G. W.,, and A. Billingsley. 1998. Corneal impression test for the diagnosis of acute rabies encephalitis. Ophthalmology 105: 249– 251.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.